Interpretation of NOTCH3 mutations in the diagnosis of CADASIL
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
CADASIL is an autosomal dominant inherited disease, characterized by mid-adult onset of cerebrovascular disease and dementia. CADASIL is caused by mutations in the NOTCH3 gene, which encodes the NOTCH3 protein. Pathogenic mutations in CADASIL are highly distinctive in the sense that they lead to the loss or gain of a cysteine residue in 1 of the 34 EGFr domains of the NOTCH3 protein. The majority are missense mutations, but small deletions, insertions and splice-site mutations have been reported, which typically also lead to a numerical cysteine alteration. Whether numerical cysteine-altering mutations are a rule in CADASIL remains subject of debate, as there are reports suggesting pathogenicity of other types of mutations. However, for most of these the association with CADASIL was later revoked or is questionable. Here, we discuss and provide recommendations for the interpretation of NOTCH3 mutations in the diagnosis of CADASIL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068 · cited 2×
“CADASIL was first described as a clearly defined and separate disease entity in the early 1990s [1–3], followed by the identification of mutations in the NOTCH3 gene in 1996 [4].”
BackgroundChabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08083-5 · Cited by 682 · cited 2×
“The prevalence of mutations in other exons varies between countries; in the French, German and English CADASIL population, exon 3 is the second most frequently mutated exon [13,53,55], whereas in Dutch CADASIL patients, exon 11 is the second most frequently mutated exon [56].”
BackgroundClinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669
Patterns of MRI lesions in CADASIL
Chabriat, H., Levy, C., Taillia, H., Iba-Zizen, M.-T., Vahedi, K., Joutel, A., Tournier-Lasserve, E., & Bousser, M.-G. (1998) · Neurology · doi:10.1212/wnl.51.2.452 · Cited by 339 · cited 1×
“Lacunar infarcts, most readily detected on T1-weighted images, can be seen from the age of 30 onward, and are found in the basal ganglia, thalamus, brainstem and subcortical white matter [37].”
BackgroundDiagnostic strategies in CADASIL
Markus, H. S., Martin, R. J., Simpson, M. A., Dong, Y. B., Ali, N., Crosby, A. H., & Powell, J. F. (2002) · Neurology · doi:10.1212/wnl.59.8.1134 · Cited by 335
Cerebral Microbleeds in CADASIL: A Gradient-Echo Magnetic Resonance Imaging and Autopsy Study
Dichgans, M., Holtmannspötter, M., Herzog, J., Peters, N., Bergmann, M., & Yousry, T. A. (2002) · Stroke · doi:10.1161/hs0102.100885 · Cited by 293
The Natural History of CADASIL: A Pooled Analysis of Previously Published Cases
Desmond, D. W., Moroney, J. T., Lynch, T., Chan, S., Chin, S. S., & Mohr, J. P. (1999) · Stroke · doi:10.1161/01.str.30.6.1230 · Cited by 269
Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis
Joutel, A., Favrole, P., Labauge, P., Chabriat, H., Lescoat, C., Andreux, F., Domenga, V., Cécillon, M., Vahedi, K., Ducros, A., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07142-2 · Cited by 252
Adib-Samii, P., Brice, G., Martin, R. J., & Markus, H. S. (2010) · Stroke · doi:10.1161/strokeaha.109.568402 · Cited by 239 · cited 3×
“The migraine attacks are often the presenting clinical symptom with a mean age at onset of around 26 years, and are remarkable by the high prevalence of auras (90% of patients) [24,27].”
BackgroundAuer, D. P., Pütz, B., Gössl, C., Elbel, G.-K., Gasser, T., & Dichgans, M. (2001) · Radiology · doi:10.1148/radiology.218.2.r01fe24443 · Cited by 223
Cerebral microbleeds in CADASIL
Lesnik Oberstein, S. A. J., van den Boom, R., van Buchem, M. A., van Houwelingen, H. C., Bakker, E., Vollebregt, E., Ferrari, M. D., Breuning, M. H., & Haan, J. (2001) · Neurology · doi:10.1212/wnl.57.6.1066 · Cited by 218
Self-citationPeters, N., Opherk, C., Danek, A., Ballard, C., Herzog, J., & Dichgans, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2078 · Cited by 178
Quantitative MRI in CADASIL: Correlation with disability and cognitive performance
Dichgans, M., Filippi, M., Brüning, R., Iannucci, G., Berchtenbreiter, C., Minicucci, L., Uttner, I., Crispin, A., Ludwig, H., Gasser, T., et al. (1999) · Neurology · doi:10.1212/wnl.52.7.1361 · Cited by 120
Schmidt, H., Zeginigg, M., Wiltgen, M., Freudenberger, P., Petrovic, K., Cavalieri, M., Gider, P., Enzinger, C., Fornage, M., Debette, S., et al. (2011) · Brain · doi:10.1093/brain/awr252 · Cited by 112
Characteristics of CADASIL in Korea: A novel cysteine-sparing Notch3 mutation
Kim, Y., Choi, E. J., Choi, C. G., Kim, G., Choi, J. H., Yoo, H. W., & Kim, J. S. (2006) · Neurology · doi:10.1212/01.wnl.0000216259.99811.50 · Cited by 98
Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL
Mayer, M., Straube, A., Bruening, R., Uttner, I., Pongratz, D., Gasser, T., Dichgans, M., & Müller-Höcker, J. (1999) · Journal of Neurology · doi:10.1007/s004150050398 · Cited by 97
A new de novo Notch3 mutation causing CADASIL
Coto, E., Menéndez, M., Navarro, R., García‐Castro, M., & Alvarez, V. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01337.x · Cited by 51
Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue
Mizuno, T., Muranishi, M., Torugun, T., Tango, H., Nagakane, Y., Kudeken, T., Kawase, Y., Kawabe, K., Oshima, F., Yaoi, T., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1391 · Cited by 49 · cited 4×
“Arg75Pro variants, respectively, sequencing of exons 2–24 was comprehensive and the diagnosis was confirmed by skin biopsy [43,74,77,81].”
BackgroundInfluentialA novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL
Mazzei, R., Conforti, F. L., Lanza, P. L., Sprovieri, T., Lupo, M. R., Gallo, O., Patitucci, A., Magariello, A., Caracciolo, M., Gabriele, A. L., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000133399.37716.84 · Cited by 48 · cited 1×
“Deletions leading to altered spacing of cysteine residues In one study, a 12-base pair deletion not involving a cysteine residue was reported to be associated with CADASIL [72].”
BackgroundCYSTEINE-SPARING NOTCH3 MUTATIONS: CADASIL OR CADASIL VARIANTS?
Scheid, R., Heinritz, W., Leyhe, T., Thal, D. R., Schober, R., Strenge, S., von Cramon, D. Y., & Froster, U. G. (2008) · Neurology · doi:10.1212/01.wnl.0000324928.44694.f7 · Cited by 31
Cited by
Di Donato, I., Bianchi, S., De Stefano, N., Dichgans, M., Dotti, M. T., Duering, M., Jouvent, E., Korczyn, A. D., Lesnik-Oberstein, S. A. J., Malandrini, A., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0778-8 · Cited by 287
Self-citationRutten, J. W., Van Eijsden, B. J., Duering, M., Jouvent, E., Opherk, C., Pantoni, L., Federico, A., Dichgans, M., Markus, H. S., Chabriat, H., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0088-3 · Cited by 169
Self-citationGenetic factors in cerebral small vessel disease and their impact on stroke and dementia
Haffner, C., Malik, R., & Dichgans, M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.71 · Cited by 109
Disease Severity Staging System for NOTCH3 -Associated Small Vessel Disease, Including CADASIL
Gravesteijn, G., Rutten, J. W., Cerfontaine, M. N., Hack, R. J., Liao, Y.-C., Jolly, A. A., Guey, S., Hsu, S.-L., Park, J.-Y., Yuan, Y., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2024.4487 · Cited by 25
Self-citation
Metadata
- Authors
- Rutten, J. W., Haan, J., Terwindt, G. M., van Duinen, S. G., Boon, E. M., & Lesnik Oberstein, S. A.
- Venue
- Expert Review of Molecular Diagnostics
- Publisher
- Informa UK Limited
- Published
- 2014-05-21
- Volume
- 14
- Issue
- 5
- Pages
- 593-603
- ISSN
- 1473-7159 (ISSN-L)
- 1744-8352
- OpenAlex
- W2117300880
- Cited by
- 124
- References
- 21
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.